Sylvester researchers Dr. Sophia George and Dr. Matthew Schlumbrecht extended their niraparib study for ovarian cancer to Africa, focusing on women of African descent. The study aims to determine drug safety, effectiveness, and appropriate dosing in this underrepresented population, highlighted by the White House in the Biden Cancer Moonshot initiative.